Dr. Edeltraut Kröger
Center of Excellence in Aging,
Faculty of pharmacy of Laval University
Dr. Edeltraut Kröger is a pharmacist and epidemiologist at the Center of Excellence in Aging in Quebec City and a professor at the Faculty of pharmacy of Laval University. Her research has helped to identify risk factors for dementia and now focusses on improving medication use in seniors. One of her main interests is to implement and assess successful interventions to decrease use of inappropriate medications in seniors. Since 2016, together with Dr. Clermont Dionne, she investigates the use of medical cannabis among persons with chronic musculoskeletal pain.
Prof. Gary J. Macfarlane
Research and Knowledge Exchange,
The University of Aberdeen
Gary Macfarlane is Dean of Research and Knowledge Exchange (Life Sciences and Medicine) at The University of Aberdeen. He has also been Chair in Epidemiology since 2005. He is an Honorary Consultant in Public Health with NHS Grampian. He trained in Statistics/Computing Science and then Medicine at The University of Glasgow before undertaking his PhD on the Epidemiology of Oral Cancer at The University of Bristol. He worked at the Division of Epidemiology and Biostatistics at the European Institute of Oncology in Milan 1991-1995 before leading a programme of chronic pain research at the Arthritis Research UK Epidemiology Unit at the University of Manchester, where he was appointed as chair in 1999. He currently leads the Epidemiology group at the University of Aberdeen which undertakes work on Rheumatic and Musculoskeletal Diseases (RMD). The RMD programme focuses on: mechanistic research, clinical trials and health services research with a clinical focus on musculoskeletal pain and fatigue (including fibromyalgia), spondyloarthritis and rare diseases (vasculitis). The programme runs the British Society of Rheumatology (BSR) Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) and Psoriatic Arthritis (BSR-PsA). He is a senior investigator within the Arthritis Research UK/Medical Research Council Centre for Musculoskeletal Health and Work (with University of Southampton). Professor Macfarlane is a Chartered Statistician of the Royal Statistical Society as well as a Fellow of the Faculty of Public Health Medicine.
Dr. Laura Stone
Associate Professor
Alan Edwards Centre for Research on Pain
Faculty of Dentistry
McGill University
Dr. Stone received her PhD in Neuroscience at the University of Minnesota and post-doctoral training in neurophysiology at the Oregon Health and Sciences University. After working in both biotechnology and academia, she joined the Faculty at McGill University where she is now an Associate Professor in the Alan Edwards Centre for Research on Pain, Faculty of Dentistry. Dr. Stone is an inventor on 7 patents and has co-authored over 70 manuscripts. Current research projects utilize both pre-clinical models and patient populations to investigate mechanisms underlying low back pain, the optimization of pharmacological and non-pharmacological treatments and the epigenetic regulation of chronic pain.
Prof. Maurits van Tulder, PhD
Professor
Health Technology Assessment,
Department of Health Sciences,
Vrije Universiteit
Maurits van Tulder is professor of Health Technology Assessment and head of the department of Health Sciences at the Vrije Universiteit in Amsterdam, the Netherlands. He also has a position as professor of Evidence-Based Physiotherapy & Occupational Therapy at Aarhus University Hospital, Aarhus, Denmark. His main research interest is effectiveness and cost-effectiveness of interventions. He has ample expertise in designing and analysing randomized controlled trials, economic evaluations and systematic reviews in the field of musculoskeletal disorders. He was one of the principal investigators responsible for the MinT trial on the effect of radiofrequency denervation for patients with chronic low back pain.
Maurits van Tulder was co-editor of the Cochrane Back and Neck Group from 2006-2017 and has been chairman or committee member for at least 5 low back pain and several other national and international clinical guidelines.
